Europe Infectious Respiratory Disease Diagnostics Market Size, Share & Industry Trends Analysis Report By Product Type, By Application, By Sample Type, By Technology (Molecular Diagnostics, Microbiology, Immunoassay), By End-use, By Country and Growth Forecast, 2022 - 2028

The Europe Infectious Respiratory Disease Diagnostics Market would witness market growth of -5.6% CAGR during the forecast period (2022-2028).

The clinical presentation of the patient and a number of diagnostic assays are used in current methods of diagnosis and surveillance. This could be difficult, though, because the clinical presentation for respiratory infections is sometimes insufficient for identification due to overlapping symptoms. Over the past few years, laboratory diagnosis of respiratory infections has advanced significantly, enabling prompt and useful results to be given to patients.

In recent years, laboratory diagnostic testing for respiratory tests has developed quickly. Direct fluorescent antigen (DFA) testing, quick serological assays, conventional microbiological respiratory cultures, and pathogen-specific molecular assays are only a few of the numerous methods and assays used in laboratories. Each has a specific function and is essential to the lab.

Numerous conventional testing techniques, such as culture, DFA, and quick testing, are arbitrary and reliant on the approach and experience of the user. Additionally, DFA is subjected to suitable lower respiratory tract digestion and photobleaching. The turnaround time of these traditional techniques is another drawback. Many conventional techniques could take several hours to accomplish, let alone days or weeks. Rapid serology-based assays are on the other end of the spectrum. These rapid assays, whether used at the point of care or in the lab, provide a quick check to see if a specific pathogen is present. Positives are often verified using traditional microbiology techniques. Rapid tests offer a rapid screening but are less sensitive than traditional microbiological.

Over the projected period, Europe is anticipated to experience a significant growth rate. The rising emergence of respiratory indications as well as rising testing rates is both responsible for the region's expansion. The NHS experiences significant pressures during the winter because of respiratory diseases; the majority of these admissions are non-elective and more than double during this time. A large number of people in the region are affected by respiratory disease, which is the third leading cause of death there (after cancer and cardiovascular disease).

The Germany market dominated the Europe Infectious Respiratory Disease Diagnostics Market by Country in 2021; thereby, achieving a market value of $2.4 billion by 2028. The UK market is exhibiting a CAGR of -6.4% during (2022 - 2028). Additionally, The France market would showcase a CAGR of -4.9% during (2022 - 2028).

Based on Product Type, the market is segmented into Consumables, Instruments (Imaging Tests, Respiratory Measurement Devices, and Others), Services. Based on Application, the market is segmented into SARS/COVID 19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, and Others. Based on Sample Type, the market is segmented into Saliva, Anterior Nasal Region, Blood, Nasopharyngeal Swabs (NPS), and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Microbiology, Immunoassay, and Others. Based on End-use, the market is segmented into Diagnostic Laboratories, Hospitals, and Physician Offices & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Infectious Respiratory Disease Diagnostics Market will Hit $ 37.2 Billion by 2028, at a CAGR of -5.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Qiagen N.V., Bio-Rad Laboratories, Inc., Danaher Corporation, Quidel Corporation

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Consumables
• Instruments
  • Imaging Tests
  • Respiratory Measurement Devices
  • Others
• Services

By Application

• SARS/COVID 19
• Influenza
• RSV (Respiratory Syncytial Virus)
• Tuberculosis
• Streptococcus Testing
• Others

By Sample Type

• Saliva
• Anterior Nasal Region
• Blood
• Nasopharyngeal Swabs (NPS)
• Others

By Technology

• Molecular Diagnostics
• Microbiology
• Immunoassay
• Others

By End Use

• Diagnostic Laboratories
• Hospitals
• Physician Offices & Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Becton, Dickinson and Company
• Siemens Healthineers AG (Siemens AG)
• Thermo Fisher Scientific, Inc.
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Quidel Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Infectious Respiratory Disease Diagnostics Market, by Product Type
1.4.2 Europe Infectious Respiratory Disease Diagnostics Market, by Application
1.4.3 Europe Infectious Respiratory Disease Diagnostics Market, by Sample Type
1.4.4 Europe Infectious Respiratory Disease Diagnostics Market, by Technology
1.4.5 Europe Infectious Respiratory Disease Diagnostics Market, by End Use
1.4.6 Europe Infectious Respiratory Disease Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.2.5 Approval & Trails:
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Mar – 2022, Jun) Leading Players

Chapter 4. Europe Infectious Respiratory Disease Diagnostics Market by Product Type
4.1 Europe Consumables Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type
4.3.1 Europe Imaging Tests Market by Country
4.3.2 Europe Respiratory Measurement Devices Market by Country
4.3.3 Europe Others Market by Country
4.4 Europe Services Market by Country

Chapter 5. Europe Infectious Respiratory Disease Diagnostics Market by Application
5.1 Europe SARS/COVID 19 Market by Country
5.2 Europe Influenza Market by Country
5.3 Europe RSV (Respiratory Syncytial Virus) Market by Country
5.4 Europe Tuberculosis Market by Country
5.5 Europe Streptococcus Testing Market by Country
5.6 Europe Others Market by Country

Chapter 6. Europe Infectious Respiratory Disease Diagnostics Market by Sample Type
6.1 Europe Saliva Market by Country
6.2 Europe Anterior Nasal Region Market by Country
6.3 Europe Blood Market by Country
6.4 Europe Nasopharyngeal Swabs (NPS) Market by Country
6.5 Europe Others Market by Country

Chapter 7. Europe Infectious Respiratory Disease Diagnostics Market by Technology
7.1 Europe Molecular Diagnostics Market by Country
7.2 Europe Microbiology Market by Country
7.3 Europe Immunoassay Market by Country
7.4 Europe Others Market by Country

Chapter 8. Europe Infectious Respiratory Disease Diagnostics Market by End-use
8.1 Europe Diagnostic Laboratories Market by Country
8.2 Europe Hospitals Market by Country
8.3 Europe Physician Offices & Others Market by Country

Chapter 9. Europe Infectious Respiratory Disease Diagnostics Market by Country
9.1 Germany Infectious Respiratory Disease Diagnostics Market
9.1.1 Germany Infectious Respiratory Disease Diagnostics Market by Product Type
9.1.1.1 Germany Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.1.2 Germany Infectious Respiratory Disease Diagnostics Market by Application
9.1.3 Germany Infectious Respiratory Disease Diagnostics Market by Sample Type
9.1.4 Germany Infectious Respiratory Disease Diagnostics Market by Technology
9.1.5 Germany Infectious Respiratory Disease Diagnostics Market by End-use
9.2 UK Infectious Respiratory Disease Diagnostics Market
9.2.1 UK Infectious Respiratory Disease Diagnostics Market by Product Type
9.2.1.1 UK Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.2.2 UK Infectious Respiratory Disease Diagnostics Market by Application
9.2.3 UK Infectious Respiratory Disease Diagnostics Market by Sample Type
9.2.4 UK Infectious Respiratory Disease Diagnostics Market by Technology
9.2.5 UK Infectious Respiratory Disease Diagnostics Market by End-use
9.3 France Infectious Respiratory Disease Diagnostics Market
9.3.1 France Infectious Respiratory Disease Diagnostics Market by Product Type
9.3.1.1 France Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.3.2 France Infectious Respiratory Disease Diagnostics Market by Application
9.3.3 France Infectious Respiratory Disease Diagnostics Market by Sample Type
9.3.4 France Infectious Respiratory Disease Diagnostics Market by Technology
9.3.5 France Infectious Respiratory Disease Diagnostics Market by End-use
9.4 Russia Infectious Respiratory Disease Diagnostics Market
9.4.1 Russia Infectious Respiratory Disease Diagnostics Market by Product Type
9.4.1.1 Russia Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.4.2 Russia Infectious Respiratory Disease Diagnostics Market by Application
9.4.3 Russia Infectious Respiratory Disease Diagnostics Market by Sample Type
9.4.4 Russia Infectious Respiratory Disease Diagnostics Market by Technology
9.4.5 Russia Infectious Respiratory Disease Diagnostics Market by End-use
9.5 Spain Infectious Respiratory Disease Diagnostics Market
9.5.1 Spain Infectious Respiratory Disease Diagnostics Market by Product Type
9.5.1.1 Spain Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.5.2 Spain Infectious Respiratory Disease Diagnostics Market by Application
9.5.3 Spain Infectious Respiratory Disease Diagnostics Market by Sample Type
9.5.4 Spain Infectious Respiratory Disease Diagnostics Market by Technology
9.5.5 Spain Infectious Respiratory Disease Diagnostics Market by End-use
9.6 Italy Infectious Respiratory Disease Diagnostics Market
9.6.1 Italy Infectious Respiratory Disease Diagnostics Market by Product Type
9.6.1.1 Italy Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.6.2 Italy Infectious Respiratory Disease Diagnostics Market by Application
9.6.3 Italy Infectious Respiratory Disease Diagnostics Market by Sample Type
9.6.4 Italy Infectious Respiratory Disease Diagnostics Market by Technology
9.6.5 Italy Infectious Respiratory Disease Diagnostics Market by End-use
9.7 Rest of Europe Infectious Respiratory Disease Diagnostics Market
9.7.1 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Product Type
9.7.1.1 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.7.2 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Application
9.7.3 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Sample Type
9.7.4 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Technology
9.7.5 Rest of Europe Infectious Respiratory Disease Diagnostics Market by End-use

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Becton, Dickinson and Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Siemens Healthineers AG (Siemens AG)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisitions and Mergers:
10.3.5.3 Geographical Expansions:
10.3.6 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.5 Koninklijke Philips N.V.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 F. Hoffmann-La Roche Ltd.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.7 Qiagen N.V.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Product Launches and Product Expansions:
10.8 Bio-Rad laboratories, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Product Launches and Product Expansions:
10.9 Danaher Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisitions and Mergers:
10.10. Quidel Corporation
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Approvals & Trails:

TABLE 1 Europe Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Europe Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Infectious Respiratory Disease Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Infectious Respiratory Disease Diagnostics Market
TABLE 5 Acquisition and Mergers– Infectious Respiratory Disease Diagnostics Market
TABLE 6 Geographical Expansion– Infectious Respiratory Disease Diagnostics Market
TABLE 7 Approval & TRAILS – Infectious Respiratory Disease Diagnostics Market
TABLE 8 Europe Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 9 Europe Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 10 Europe Consumables Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Consumables Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe Instruments Market by Country, 2018 - 2021, USD Million
TABLE 13 Europe Instruments Market by Country, 2022 - 2028, USD Million
TABLE 14 Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 15 Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 16 Europe Imaging Tests Market by Country, 2018 - 2021, USD Million
TABLE 17 Europe Imaging Tests Market by Country, 2022 - 2028, USD Million
TABLE 18 Europe Respiratory Measurement Devices Market by Country, 2018 - 2021, USD Million
TABLE 19 Europe Respiratory Measurement Devices Market by Country, 2022 - 2028, USD Million
TABLE 20 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Services Market by Country, 2018 - 2021, USD Million
TABLE 23 Europe Services Market by Country, 2022 - 2028, USD Million
TABLE 24 Europe Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 25 Europe Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 26 Europe SARS/COVID 19 Market by Country, 2018 - 2021, USD Million
TABLE 27 Europe SARS/COVID 19 Market by Country, 2022 - 2028, USD Million
TABLE 28 Europe Influenza Market by Country, 2018 - 2021, USD Million
TABLE 29 Europe Influenza Market by Country, 2022 - 2028, USD Million
TABLE 30 Europe RSV (Respiratory Syncytial Virus) Market by Country, 2018 - 2021, USD Million
TABLE 31 Europe RSV (Respiratory Syncytial Virus) Market by Country, 2022 - 2028, USD Million
TABLE 32 Europe Tuberculosis Market by Country, 2018 - 2021, USD Million
TABLE 33 Europe Tuberculosis Market by Country, 2022 - 2028, USD Million
TABLE 34 Europe Streptococcus Testing Market by Country, 2018 - 2021, USD Million
TABLE 35 Europe Streptococcus Testing Market by Country, 2022 - 2028, USD Million
TABLE 36 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 37 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 38 Europe Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 39 Europe Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 40 Europe Saliva Market by Country, 2018 - 2021, USD Million
TABLE 41 Europe Saliva Market by Country, 2022 - 2028, USD Million
TABLE 42 Europe Anterior Nasal Region Market by Country, 2018 - 2021, USD Million
TABLE 43 Europe Anterior Nasal Region Market by Country, 2022 - 2028, USD Million
TABLE 44 Europe Blood Market by Country, 2018 - 2021, USD Million
TABLE 45 Europe Blood Market by Country, 2022 - 2028, USD Million
TABLE 46 Europe Nasopharyngeal Swabs (NPS) Market by Country, 2018 - 2021, USD Million
TABLE 47 Europe Nasopharyngeal Swabs (NPS) Market by Country, 2022 - 2028, USD Million
TABLE 48 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 49 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 50 Europe Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 Europe Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 Europe Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 53 Europe Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 54 Europe Microbiology Market by Country, 2018 - 2021, USD Million
TABLE 55 Europe Microbiology Market by Country, 2022 - 2028, USD Million
TABLE 56 Europe Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 57 Europe Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 58 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 59 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 60 Europe Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 61 Europe Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 62 Europe Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 63 Europe Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 64 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 65 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 66 Europe Physician Offices & Others Market by Country, 2018 - 2021, USD Million
TABLE 67 Europe Physician Offices & Others Market by Country, 2022 - 2028, USD Million
TABLE 68 Europe Infectious Respiratory Disease Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 69 Europe Infectious Respiratory Disease Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 70 Germany Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 71 Germany Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 72 Germany Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 73 Germany Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 74 Germany Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 75 Germany Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 76 Germany Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 77 Germany Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 78 Germany Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 79 Germany Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 80 Germany Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 81 Germany Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 82 Germany Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 83 Germany Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 84 UK Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 85 UK Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 86 UK Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 87 UK Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 88 UK Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 89 UK Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 90 UK Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 91 UK Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 92 UK Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 93 UK Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 94 UK Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 95 UK Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 96 UK Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 97 UK Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 98 France Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 99 France Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 100 France Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 101 France Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 102 France Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 103 France Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 104 France Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 105 France Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 106 France Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 107 France Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 108 France Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 109 France Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 110 France Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 111 France Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 112 Russia Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 113 Russia Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 114 Russia Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 115 Russia Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 116 Russia Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 117 Russia Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 118 Russia Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 119 Russia Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 120 Russia Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 121 Russia Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 122 Russia Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 123 Russia Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 124 Russia Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 125 Russia Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 126 Spain Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 127 Spain Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 128 Spain Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 129 Spain Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 130 Spain Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 131 Spain Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 132 Spain Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 133 Spain Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 134 Spain Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 135 Spain Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 136 Spain Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 137 Spain Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 138 Spain Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 139 Spain Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 140 Italy Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 141 Italy Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 142 Italy Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 143 Italy Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 144 Italy Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 145 Italy Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 146 Italy Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 147 Italy Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 148 Italy Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 149 Italy Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 150 Italy Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 151 Italy Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 152 Italy Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 153 Italy Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 154 Rest of Europe Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 155 Rest of Europe Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 156 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 157 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 158 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 159 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 160 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 161 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 162 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 163 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 164 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 165 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 166 Rest of Europe Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 167 Rest of Europe Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 168 Key Information – Abbott Laboratories
TABLE 169 Key information – Becton, Dickinson and Company
TABLE 170 Key Information – Siemens Healthineers AG
TABLE 171 Key Information – Thermo Fisher Scientific, Inc.
TABLE 172 Key Information – Koninklijke Philips N.V.
TABLE 173 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 174 Key Information – Qiagen N.V.
TABLE 175 Key Information – Bio-Rad Laboratories, Inc.
TABLE 176 Key Information – Danaher Corporation
TABLE 177 key information – Quidel Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2020, Mar – 2022, Jun) Leading Players
FIG 5 Recent strategies and developments: Abbott Laboratories
FIG 6 Swot analysis: Abbott laboratories
FIG 7 Recent strategies and developments: Becton, Dickinson and Company
FIG 8 Swot analysis: Becton, Dickinson and company
FIG 9 Recent strategies and developments: Siemens Healthineers AG
FIG 10 Swot analysis: Siemens AG
FIG 11 Recent strategies and developments: Thermo Fisher Scientific, Inc.